Ketamine Hydrochloride Injection 100mg/mL CIIIN and 2 more items

The University of Virginia awarded contract A207_PO-0450261 to MWI Animal Health on June 19, 2026, for the provision of pharmaceutical supplies totaling fifty-nine dollars. The contract encompasses three distinct pharmaceutical line items: Ketamine Hydrochloride Injection 100 milligrams per milliliter (a Schedule II controlled substance), 0.9% Sodium Chloride Injection in 10-milliliter units, and Rompun (Xylazine) Injectable, a sedative and analgesic formulation for equine and cervidae species in a 50-milliliter container. All deliveries are directed to Samuel Nicholas Sklar at the University of Virginia location in Virginia.

The procurement includes one unit each of the three pharmaceutical products, with unit prices of seven dollars and twelve cents, thirty-one dollars and sixty-seven cents, and twenty dollars and forty cents respectively. The contract represents a purchase order arrangement for controlled and non-controlled pharmaceutical materials, consistent with the University of Virginia's operational requirements for animal health applications. No specific contract performance period beyond the award date of June 19, 2026, is delineated in the available contract documentation.